Australia markets closed

Zymergen Inc. (ZY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1400+0.3700 (+13.36%)
At close: 04:00PM EDT
3.0500 -0.09 (-2.87%)
After hours: 07:45PM EDT
Full screen
Loading interactive chart…
  • Motley Fool

    Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the Future

    Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer.

  • PR Newswire

    Ginkgo to Acquire Zymergen

    Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen stockholders will receive a